marketcaparena
Search

    ALKS

    Alkermes plc.

    Company overview

    Market capitalization
    $6.74B
    Employees
    2,050
    Latest publication
    2026-09-29
    About Alkermes plc.

    Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. The company has a portfolio of proprietary commercial products for the treatment of opioid dependence, alcohol dependence, schizophrenia, bipolar I, and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder; and LUMRYZ, an extended-release oral suspension product for the treatment of cataplexy or EDS in pediatric patients. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ4 20212021-12-31 · USD
    Total Revenue496,009,000USD384,547,000USD394,185,000USD390,657,000USD306,510,000USD429,986,000USD378,143,000USD324,463,000USD
    Cost Of Revenue98,112,000USD46,209,000USD51,591,000USD49,460,000USD49,197,000USD62,116,000USD63,099,000USD53,682,000USD
    Gross Profit397,897,000USD338,338,000USD342,594,000USD341,197,000USD257,313,000USD367,870,000USD315,044,000USD270,781,000USD
    Research Development112,920,000USD93,038,000USD81,739,000USD77,370,000USD71,817,000USD56,674,000USD59,892,000USD98,374,000USD
    Selling General Administrative63,261,000USD100,797,000USD56,143,000USD49,674,000USD48,770,000USD48,180,000USD48,282,000USD147,169,000USD
    Selling And Marketing Expenses154,364,000USD—115,630,000USD121,175,000USD122,934,000USD98,814,000USD102,100,000USD—
    General And Administrative Expenses63,261,000USD———————
    Total Operating Expenses379,544,000USD280,234,000USD253,512,000USD248,219,000USD243,521,000USD205,182,000USD210,288,000USD268,398,000USD
    Operating Income18,353,000USD58,104,000USD89,082,000USD92,978,000USD13,792,000USD162,688,000USD104,756,000USD2,383,000USD
    Total Other Income Expense Net-20,229,000USD2,273,000USD11,663,000USD11,861,000USD11,697,000USD7,201,000USD5,474,000USD-2,156,000USD
    Interest Income5,344,000USD12,130,000USD11,943,000USD11,090,000USD10,141,000USD11,400,000USD10,916,000USD453,000USD
    Interest Expense25,925,000USD12,277,000USD0USD0USD0USD4,648,000USD6,000,000USD2,405,000USD
    Income Before Tax-1,876,000USD60,377,000USD100,745,000USD104,839,000USD25,489,000USD169,889,000USD110,230,000USD227,000USD
    Income Tax Expense-2,377,000USD11,036,000USD17,984,000USD17,741,000USD3,025,000USD24,152,000USD17,435,000USD-646,000USD
    Net Income501,000USD49,341,000USD82,761,000USD87,098,000USD22,464,000USD146,503,000USD92,381,000USD873,000USD
    Unclassified Operating Expenses—86,399,000USD—————22,855,000USD
    Net Interest Income—-147,000USD11,943,000USD11,090,000USD10,141,000USD6,752,000USD4,916,000USD-1,952,000USD
    Tax Provision—11,036,000USD17,984,000USD17,741,000USD3,025,000USD24,152,000USD17,435,000USD-646,000USD
    Net Income From Continuing Ops—49,341,000USD82,761,000USD87,098,000USD22,464,000USD145,737,000USD92,795,000USD873,000USD
    Ebit—72,654,000USD100,745,000USD104,839,000USD25,489,000USD174,537,000USD116,230,000USD2,632,000USD
    Ebitda—76,500,000USD108,825,000USD112,657,000USD32,910,000USD181,384,000USD123,202,000USD23,774,000USD
    Depreciation And Amortization—3,846,000USD8,080,000USD7,818,000USD7,421,000USD6,847,000USD6,972,000USD21,142,000USD
    Reconciled Depreciation—3,846,000USD8,080,000USD7,818,000USD7,421,000USD6,847,000USD6,972,000USD21,142,000USD
    Non Operating Income Net Other———————249,000USD
    Net Income Applicable To Common Shares———————873,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20132013-12-31 · USDFY 20122012-12-31 · USDFY 20112011-12-31 · USDFY 20072007-12-31 · USDFY 20052005-12-31 · USD
    Total Revenue1,475,899,000USD432,900,000USD575,548,000USD575,548,000USD326,839,000USD239,965,000USD
    Cost Of Revenue196,457,000USD134,300,000USD310,479,000USD170,466,000USD43,396,000USD45,209,000USD
    Gross Profit1,279,442,000USD298,600,000USD265,069,000USD405,082,000USD283,443,000USD194,756,000USD
    Research Development323,964,000USD128,100,000USD6,541,000USD140,013,000USD89,478,000USD117,315,000USD
    Selling General Administrative624,823,000USD116,600,000USD120,458,000USD137,600,000USD59,508,000USD40,383,000USD
    Unclassified Operating Expenses76,699,000USD38,400,000USD35,311,000USD45,656,000USD—26,016,000USD
    Total Operating Expenses1,025,486,000USD283,100,000USD167,610,000USD323,269,000USD148,486,000USD183,714,000USD
    Operating Income253,956,000USD15,500,000USD81,813,000USD81,813,000USD134,957,000USD11,042,000USD
    Interest Income45,304,000USD—————
    Interest Expense12,277,000USD0USD48,994,000USD48,994,000USD13,756,000USD3,818,000USD
    Net Interest Income33,027,000USD—————
    Income Before Tax291,450,000USD5,400,000USD35,441,000USD35,441,000USD131,012,000USD10,543,000USD
    Income Tax Expense49,786,000USD-12,300,000USD10,458,000USD10,458,000USD507,000USD1,098,000USD
    Tax Provision49,786,000USD—————
    Net Income241,664,000USD17,600,000USD24,983,000USD24,983,000USD130,505,000USD9,445,000USD
    Net Income From Continuing Ops241,664,000USD20,648,000USD24,983,000USD-113,678,000USD——
    Ebit303,727,000USD-4,400,000USD41,636,710USD84,435,000USD144,768,000USD11,042,000USD
    Ebitda330,892,000USD66,400,000USD115,387,710USD158,186,000USD155,033,000USD23,033,000USD
    Depreciation And Amortization27,165,000USD70,800,000USD73,751,000USD73,751,000USD10,265,000USD11,991,000USD
    Reconciled Depreciation27,165,000USD—————
    Total Other Income Expense Net37,494,000USD10,100,000USD963,000USD-46,372,000USD-3,945,000USD-499,000USD
    Net Income Applicable To Common Shares—17,649,000USD24,983,000USD-113,678,000USD166,979,000USD3,818,000USD
    Selling And Marketing Expenses——5,300,000USD———
    Non Operating Income Net Other——2,622,000USD2,000,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets4,393,125,000USD4,258,076,000USD2,530,255,000USD2,329,512,000USD2,252,809,000USD2,081,977,000USD2,055,567,000USD2,155,291,000USD
    Cash And Equivalents511,529,000USD———————
    Long Term Investments35,054,000USD26,363,000USD145,000USD27,869,000USD38,269,000USD32,189,000USD73,148,000USD18,920,000USD
    Total Current Assets1,522,906,000USD1,358,644,000USD1,929,161,000USD1,741,664,000USD1,635,288,000USD1,479,050,000USD1,415,355,000USD1,564,178,000USD
    Other Current Assets110,895,000USD102,449,000USD79,090,000USD84,442,000USD72,719,000USD89,843,000USD91,282,000USD94,047,000USD
    Other Non Current Assets62,000,000USD———————
    Total Liabilities2,584,575,000USD———————
    Total Current Liabilities662,091,000USD599,499,000USD543,437,000USD474,360,000USD505,962,000USD443,730,000USD465,199,000USD453,705,000USD
    Other Non Current Liabilities68,018,000USD———————
    Total Stockholder Equity1,808,550,000USD1,751,531,000USD1,819,295,000USD1,733,432,000USD1,624,584,000USD1,511,583,000USD1,464,977,000USD1,292,106,000USD
    Total Equity Including Noncontrolling Interest1,808,550,000USD———————
    Short Long Term Debt53,000,000USD26,500,000USD—————3,000,000USD
    Long Term Debt1,476,611,000USD1,483,837,000USD—————285,823,000USD
    Inventory298,957,000USD336,703,000USD196,625,000USD190,997,000USD191,924,000USD183,438,000USD182,887,000USD191,087,000USD
    Property Plant Equipment Net294,395,000USD298,835,000USD298,931,000USD326,110,000USD319,931,000USD316,326,000USD311,809,000USD311,498,000USD
    Goodwill594,273,000USD———————
    Intangible Assets1,761,456,000USD1,784,040,000USD83,842,000USD83,861,000USD83,880,000USD83,899,000USD890,000USD904,000USD
    Accounts Payable142,860,000USD102,357,000USD107,950,000USD67,998,000USD99,206,000USD59,840,000USD45,630,000USD37,037,000USD
    Short Term Debt7,477,000USD34,077,000USD6,746,000USD6,632,000USD6,462,000USD6,291,000USD6,166,000USD9,150,000USD
    Common Stock1,847,000USD1,836,000USD1,810,000USD1,805,000USD1,805,000USD1,802,000USD1,767,000USD1,763,000USD
    Retained Earnings-800,773,000USD-801,274,000USD-734,794,000USD-784,135,000USD-866,896,000USD-953,994,000USD-976,458,000USD-1,122,961,000USD
    Accumulated Other Comprehensive Income-2,923,000USD-2,908,000USD-2,100,000USD-1,059,000USD-1,400,000USD-1,455,000USD-1,967,000USD425,000USD
    Total Liab—2,506,545,000USD710,960,000USD596,080,000USD628,225,000USD570,394,000USD590,590,000USD863,185,000USD
    Other Current Liab—463,065,000USD428,741,000USD399,730,000USD400,294,000USD377,599,000USD412,154,000USD405,179,000USD
    Capital Stock—1,836,000USD1,810,000USD1,805,000USD1,805,000USD1,802,000USD1,767,000USD1,763,000USD
    Good Will—596,029,000USD83,842,000USD———83,027,000USD83,027,000USD
    Other Assets—240,054,000USD936,604,000USD—————
    Cash—351,551,000USD1,119,776,000USD616,449,000USD521,199,000USD399,806,000USD291,146,000USD396,293,000USD
    Cash And Short Term Investments—511,862,000USD1,319,421,000USD1,111,114,000USD1,015,739,000USD884,017,000USD751,668,000USD908,864,000USD
    Net Debt—1,230,109,000USD-1,049,777,000USD-544,851,000USD-448,521,000USD-325,704,000USD-215,608,000USD-30,290,000USD
    Short Long Term Debt Total—1,581,660,000USD69,999,000USD71,598,000USD72,678,000USD74,102,000USD75,538,000USD366,003,000USD
    Short Term Investments—160,311,000USD199,645,000USD494,665,000USD494,540,000USD484,211,000USD460,522,000USD512,571,000USD
    Net Receivables—407,630,000USD334,025,000USD355,111,000USD354,906,000USD321,752,000USD389,518,000USD370,180,000USD
    Property Plant Equipment Gross—574,060,000USD565,941,000USD589,704,000USD584,856,000USD576,740,000USD564,821,000USD560,568,000USD
    Common Stock Shares Outstanding—166,196,000shares168,743,000shares168,510,000shares168,357,000shares168,737,000shares166,554,000shares167,025,000shares
    Non Current Assets Total—2,899,432,000USD601,094,000USD587,848,000USD617,521,000USD602,927,000USD640,212,000USD591,113,000USD
    Non Current Liabilities Total—1,907,046,000USD167,523,000USD121,720,000USD122,263,000USD126,664,000USD125,391,000USD409,480,000USD
    Non Current Liabilities Other—177,543,000USD61,008,000USD56,754,000USD56,047,000USD58,853,000USD56,019,000USD52,627,000USD
    Non Currrent Assets Other—59,357,000USD49,099,000USD19,664,000USD19,908,000USD18,369,000USD16,503,000USD16,804,000USD
    Net Working Capital—759,145,000USD1,385,724,000USD1,267,304,000USD1,129,326,000USD1,035,320,000USD950,156,000USD1,110,473,000USD
    Unclassified Non Current Assets—-105,246,000USD-851,369,000USD130,344,000USD155,533,000USD152,144,000USD154,835,000USD159,960,000USD
    Unclassified Current Liabilities—-26,500,000USD——————
    Unclassified Non Current Liabilities—245,666,000USD106,515,000USD64,966,000USD66,216,000USD67,811,000USD69,372,000USD71,030,000USD
    Unclassified Equity—2,552,041,000USD2,552,569,000USD2,515,016,000USD2,489,270,000USD2,463,428,000USD2,439,868,000USD2,411,116,000USD
    Current Deferred Revenue——————1,249,000USD2,339,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets2,530,255,000USD2,055,567,000USD2,136,223,000USD1,963,978,000USD2,024,484,000USD1,949,730,000USD1,805,403,000USD1,825,007,000USD
    Intangible Assets83,842,000USD890,000USD1,991,000USD37,680,000USD74,043,000USD111,191,000USD150,643,000USD191,001,000USD
    Other Current Assets79,090,000USD91,282,000USD192,426,000USD43,527,000USD48,967,000USD60,662,000USD59,716,000USD53,308,000USD
    Total Liab710,960,000USD590,590,000USD933,537,000USD920,225,000USD911,900,000USD882,748,000USD719,961,000USD653,722,000USD
    Total Stockholder Equity1,819,295,000USD1,464,977,000USD1,202,686,000USD1,043,753,000USD1,112,584,000USD1,066,982,000USD1,085,442,000USD1,171,285,000USD
    Other Current Liab428,741,000USD412,154,000USD443,095,000USD445,205,000USD389,986,000USD366,137,000USD318,776,000USD293,995,000USD
    Common Stock1,810,000USD1,767,000USD1,726,000USD1,690,000USD1,658,000USD1,620,000USD1,602,000USD1,579,000USD
    Capital Stock1,810,000USD1,767,000USD1,726,000USD1,690,000USD1,658,000USD1,620,000USD1,602,000USD1,579,000USD
    Retained Earnings-734,794,000USD-976,458,000USD-1,343,528,000USD-1,699,285,000USD-1,541,018,000USD-1,492,849,000USD-1,381,988,000USD-1,185,368,000USD
    Good Will83,842,000USD83,027,000USD83,027,000USD83,027,000USD92,873,000USD92,873,000USD92,873,000USD92,873,000USD
    Other Assets936,604,000USD—1USD122,393,000USD224,915,000USD284,692,000USD140,079,000USD161,650,000USD
    Cash1,119,776,000USD291,146,000USD457,469,000USD292,473,000USD337,544,000USD272,961,000USD203,771,000USD266,762,000USD
    Cash And Short Term Investments1,319,421,000USD751,668,000USD773,491,000USD608,465,000USD536,311,000USD635,027,000USD534,979,000USD539,295,000USD
    Total Current Assets1,929,161,000USD1,415,355,000USD1,485,506,000USD1,130,306,000USD1,062,169,000USD1,110,971,000USD961,970,000USD983,252,000USD
    Total Current Liabilities543,437,000USD465,199,000USD520,220,000USD497,742,000USD471,286,000USD438,258,000USD391,112,000USD339,774,000USD
    Net Debt-1,049,777,000USD-215,608,000USD-85,284,000USD86,962,000USD78,662,000USD137,196,000USD87,175,000USD12,546,000USD
    Short Term Debt6,746,000USD6,166,000USD8,746,000USD12,878,000USD19,240,000USD18,575,000USD11,309,000USD2,843,000USD
    Short Long Term Debt Total69,999,000USD75,538,000USD372,185,000USD379,435,000USD416,206,000USD410,157,000USD290,946,000USD279,308,000USD
    Long Term Investments145,000USD73,148,000USD39,887,000USD131,610,000USD229,430,000USD24,780,000USD79,391,000USD80,744,000USD
    Short Term Investments199,645,000USD460,522,000USD316,022,000USD315,992,000USD198,767,000USD362,066,000USD331,208,000USD272,533,000USD
    Net Receivables334,025,000USD389,518,000USD333,183,000USD296,896,000USD326,556,000USD289,544,000USD265,472,000USD300,453,000USD
    Inventory196,625,000USD182,887,000USD186,406,000USD181,418,000USD150,335,000USD125,738,000USD101,803,000USD90,196,000USD
    Accounts Payable107,950,000USD45,630,000USD65,649,000USD32,843,000USD55,721,000USD46,034,000USD54,261,000USD39,767,000USD
    Property Plant Equipment Net298,931,000USD311,809,000USD318,403,000USD320,458,000USD456,681,000USD481,721,000USD374,547,000USD309,987,000USD
    Property Plant Equipment Gross565,941,000USD564,821,000USD548,564,000USD874,874,000USD852,244,000USD481,721,000USD362,168,000USD309,987,000USD
    Accumulated Other Comprehensive Income-2,100,000USD-1,967,000USD-3,110,000USD-10,889,000USD-3,723,000USD-1,349,000USD-1,816,000USD-3,280,000USD
    Common Stock Shares Outstanding168,743,000shares169,198,000shares169,730,000shares163,742,000shares160,942,000shares158,803,000shares157,051,000shares155,112,000shares
    Non Current Assets Total601,094,000USD640,212,000USD650,717,000USD833,672,000USD962,315,000USD838,759,000USD843,433,000USD841,755,000USD
    Non Current Liabilities Total167,523,000USD125,391,000USD413,317,000USD422,483,000USD440,614,000USD444,490,000USD328,849,000USD313,948,000USD
    Non Current Liabilities Other61,008,000USD56,019,000USD49,878,000USD132,213,000USD147,810,000USD172,372,000USD54,554,000USD37,483,000USD
    Non Currrent Assets Other49,099,000USD16,503,000USD11,521,000USD146,325,000USD27,455,000USD41,966,000USD49,421,000USD81,343,000USD
    Net Working Capital1,385,724,000USD950,156,000USD965,286,000USD764,174,000USD590,883,000USD672,713,000USD570,858,000USD643,478,000USD
    Unclassified Non Current Assets-851,369,000USD154,835,000USD195,887,999USD—-143,082,000USD-198,464,000USD-43,521,000USD-75,843,000USD
    Unclassified Non Current Liabilities106,515,000USD69,372,000USD75,709,000USD-42,384,000USD-147,810,000USD-52,908,000USD-49,212,000USD-37,483,000USD
    Unclassified Equity2,552,569,000USD2,439,868,000USD2,545,872,000USD2,750,547,000USD2,654,009,000USD2,557,940,000USD2,584,428,000USD2,465,744,000USD
    Current Deferred Revenue—1,249,000USD2,730,000USD6,816,000USD6,339,000USD7,512,000USD6,766,000USD3,169,000USD
    Short Long Term Debt——3,000,000USD3,000,000USD3,000,000USD2,843,000USD2,843,000USD2,843,000USD
    Long Term Debt——287,730,000USD290,270,000USD292,804,000USD272,118,000USD274,295,000USD276,465,000USD
    Other Liab———42,384,000USD147,810,000USD52,908,000USD49,212,000USD37,483,000USD
    Net Tangible Assets———913,200,000USD945,668,000USD862,918,000USD841,926,000USD887,411,000USD
    Treasury Stock——————-118,386,000USD-108,969,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation49,705,000USD
    Stock Based Compensation67,469,000USD
    Deferred Income Tax317,000USD
    Change To Inventory1,014,000USD
    Change To Liabilities-71,276,000USD
    Change In Working Capital-70,262,000USD
    Operating Cash Flow-20,560,000USD
    Capital Expenditures-12,236,000USD
    Net Investments80,582,000USD
    Other Investing Activities-2,085,073,000USD
    Unclassified Investing Cash Flow-62,684,000USD
    Investing Cash Flow-2,079,411,000USD
    Net Debt Issuance1,504,932,000USD
    Common Stock Issuance42,006,000USD
    Net Common Stock Issuance-52,234,000USD
    Unclassified Financing Cash Flow-2,980,000USD
    Financing Cash Flow1,491,724,000USD
    Change In Cash-608,247,000USD
    End Cash Flow511,529,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-66,480,000USD49,341,000USD82,761,000USD87,098,000USD22,464,000USD146,503,000USD92,381,000USD94,658,000USD
    Depreciation19,429,000USD3,846,000USD8,080,000USD7,818,000USD7,421,000USD6,847,000USD6,972,000USD6,658,000USD
    Stock Based Compensation36,330,000USD-72,441,000USD24,665,000USD24,966,000USD22,810,000USD20,748,000USD22,533,000USD20,601,000USD
    Other Non Cash Items50,350,000USD128,405,000USD1,151,000USD2,971,000USD274,000USD1,180,000USD2,658,000USD15,760,000USD
    Change To Account Receivables-22,468,000USD15,469,000USD789,000USD-31,200,000USD45,109,000USD-19,339,000USD18,290,000USD-30,251,000USD
    Change To Inventory-6,427,000USD-4,863,000USD845,000USD-8,292,000USD-1,751,000USD9,142,000USD3,487,000USD3,103,000USD
    Change In Working Capital-160,255,000USD91,412,000USD-46,379,000USD30,756,000USD43,335,000USD6,910,000USD-53,544,000USD14,745,000USD
    Total Cash From Operating Activities-165,743,000USD170,069,000USD101,672,000USD150,202,000USD98,811,000USD190,397,000USD81,589,000USD146,030,000USD
    Capital Expenditures-4,090,000USD-20,000USD-17,314,000USD-13,016,000USD-10,110,000USD-9,773,000USD-8,258,000USD-7,111,000USD
    Free Cash Flow-169,833,000USD170,089,000USD84,358,000USD137,186,000USD88,701,000USD180,624,000USD73,331,000USD138,919,000USD
    Investments12,154,000USD321,274,000USD-6,737,000USD-29,214,000USD9,102,000USD-13,875,000USD-109,332,000USD51,850,000USD
    Total Cashflows From Investing Activities-2,077,000,000USD322,346,000USD-6,737,000USD-29,214,000USD9,102,000USD-13,875,000USD-109,332,000USD51,850,000USD
    Net Borrowings1,511,557,000USD0USD0USD0USD0USD-289,542,000USD-750,000USD—
    Total Cash From Financing Activities1,474,519,000USD10,912,000USD315,000USD405,000USD747,000USD-281,669,000USD-111,114,000USD-83,483,000USD
    Sale Purchase Of Stock-27,696,000USD-31,032,000USD28,781,000USD-1,678,000USD-28,781,000USD-1,000USD-115,592,000USD-85,340,000USD
    Change In Cash-768,225,000USD503,327,000USD95,250,000USD121,392,999USD108,660,000USD-105,147,000USD-138,857,000USD114,397,000USD
    Begin Period Cash Flow1,119,776,000USD616,449,000USD521,198,999USD399,806,000USD291,146,000USD396,293,000USD535,150,000USD420,753,000USD
    End Period Cash Flow351,551,000USD1,119,776,000USD616,449,000USD521,198,999USD399,806,000USD291,146,000USD396,293,000USD535,150,000USD
    Other Cashflows From Financing Activities-1,536,613,000USD30,766,000USD-307,000USD-1,678,000USD-28,781,000USD-344,000USD-293,000USD2,607,000USD
    Unclassified Operating Cash Flow-45,117,000USD-30,494,000USD31,394,000USD-3,407,000USD2,507,000USD8,209,000USD10,589,000USD-6,392,000USD
    Unclassified Investing Cash Flow-2,085,064,000USD—17,314,000USD12,987,000USD8,397,000USD9,766,000USD8,238,000USD-90,822,000USD
    Unclassified Financing Cash Flow1,527,271,000USD11,178,000USD-28,159,000USD3,761,000USD58,309,000USD8,218,000USD5,521,000USD—
    Other Cashflows From Investing Activities—-1,446,500USD—29,000USD1,713,000USD7,000USD20,000USD97,933,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income241,664,000USD367,070,000USD355,757,000USD-158,267,000USD-48,169,000USD-110,861,000USD-196,620,000USD-139,311,000USD
    Depreciation27,165,000USD28,533,000USD74,927,000USD77,862,000USD78,652,000USD81,854,000USD80,413,000USD103,660,000USD
    Stock Based Compensation98,716,000USD96,637,000USD100,905,000USD94,254,000USD87,622,000USD90,164,000USD100,977,000USD105,357,000USD
    Other Non Cash Items5,311,000USD4,512,000USD6,329,000USD27,281,000USD4,077,000USD-1,431,000USD22,220,000USD26,372,000USD
    Change To Account Receivables55,493,000USD-56,336,000USD-44,510,000USD25,250,000USD-38,011,000USD-18,050,000USD29,980,000USD-58,632,000USD
    Change To Inventory-14,061,000USD3,091,000USD-2,712,000USD-31,021,000USD-24,769,000USD-22,933,000USD-13,077,000USD-2,665,000USD
    Change In Working Capital119,124,000USD-98,150,000USD-36,663,000USD12,709,000USD-25,548,000USD13,131,000USD65,406,000USD-7,420,000USD
    Total Cash From Operating Activities520,754,000USD439,124,000USD401,353,000USD21,044,000USD101,715,000USD82,842,000USD72,077,000USD99,281,000USD
    Capital Expenditures-40,420,000USD-33,484,000USD-48,048,000USD-38,255,000USD-29,020,000USD-42,219,000USD-90,942,000USD-69,431,000USD
    Free Cash Flow480,334,000USD405,640,000USD353,305,000USD-17,211,000USD72,695,000USD40,623,000USD-18,865,000USD29,850,000USD
    Investments333,123,000USD-111,308,000USD102,079,000USD-28,044,000USD-45,408,000USD23,458,000USD-52,916,000USD46,729,000USD
    Total Cashflows From Investing Activities295,497,000USD-111,308,000USD53,357,000USD-64,541,000USD-66,204,000USD-11,481,000USD-141,833,000USD-22,195,000USD
    Net Borrowings0USD-291,792,000USD-3,000,000USD-3,000,000USD20,324,000USD-2,843,000USD-2,843,000USD-2,875,000USD
    Total Cash From Financing Activities12,379,000USD-494,139,000USD-289,714,000USD-1,574,000USD29,072,000USD-2,171,000USD6,765,000USD-1,620,000USD
    Sale Purchase Of Stock-31,032,000USD-200,282,000USD-28,474,000USD-18,204,000USD-16,571,000USD-7,701,000USD-9,317,000USD-19,622,000USD
    Change In Cash828,630,000USD-166,323,000USD164,996,000USD-45,071,000USD64,583,000USD69,190,000USD-62,991,000USD75,466,000USD
    Begin Period Cash Flow291,146,000USD457,469,000USD292,473,000USD337,544,000USD272,961,000USD203,771,000USD266,762,000USD191,296,000USD
    End Period Cash Flow1,119,776,000USD291,146,000USD457,469,000USD292,473,000USD337,544,000USD272,961,000USD203,771,000USD266,762,000USD
    Other Cashflows From Investing Activities295,500USD461,000USD354,000USD1,273,000USD8,937,000USD4,529,000USD10,000,000USD507,000USD
    Other Cashflows From Financing Activities12,400USD-29,637,000USD-275,000,000USD1,426,000USD8,748,000USD672,000USD9,608,000USD-877,000USD
    Unclassified Operating Cash Flow28,774,000USD40,522,000USD-99,902,000USD-32,795,000USD5,081,000USD9,985,000USD—10,623,000USD
    Unclassified Financing Cash Flow43,398,600USD27,572,000USD16,760,000USD19,630,000USD25,319,000USD8,372,999USD18,925,000USD21,754,000USD
    Unclassified Investing Cash Flow—33,023,000USD-1,028,000USD——2,751,000USD-7,975,000USD—
    Change To Liabilities———28,260,000USD25,520,000USD59,968,000USD34,865,000USD55,735,000USD
    Dividends Paid———-1,426,000USD-8,748,000USD-671,999USD-9,608,000USD—
    Cash And Cash Equivalents Changes———-45,071,000USD64,583,000USD69,190,000USD-62,991,000USD75,466,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30ProductAristada And Aristada Initio96,719,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductLUMRYZ96,572,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductLYBALVI93,979,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductManufactured Product And Royalty — Manufacturing Revenue20,901,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductRoyalty63,384,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductVivitrol124,454,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31ProductAristada And Aristada Initio93,824,000USD0001193125-26-206534
    Q1 2026Quarterly · 2026-03-31ProductLUMRYZ39,492,000USD0001193125-26-206534
    Q1 2026Quarterly · 2026-03-31ProductLYBALVI92,364,000USD0001193125-26-206534
    Q1 2026Quarterly · 2026-03-31ProductManufactured Product And Royalty — Manufacturing Revenue4,068,000USD0001193125-26-206534
    Q1 2026Quarterly · 2026-03-31ProductRoyalty50,729,000USD0001193125-26-206534
    Q1 2026Quarterly · 2026-03-31ProductVivitrol112,434,000USD0001193125-26-206534
    FY 2025Yearly · 2025-12-31GeographyForeign Country Excluding Specified Country102,358,000USD0001193125-26-068925
    FY 2025Yearly · 2025-12-31GeographyIE754,000USD0001193125-26-068925
    FY 2025Yearly · 2025-12-31GeographyUnited States1,372,787,000USD0001193125-26-068925
    FY 2025Yearly · 2025-12-31ProductAristada And Aristada Initio370,044,000USD0001193125-26-068925
    FY 2025Yearly · 2025-12-31ProductLYBALVI346,687,000USD0001193125-26-068925
    FY 2025Yearly · 2025-12-31ProductManufactured Product And Royalty — Manufacturing Revenue45,995,000USD0001193125-26-068925
    FY 2025Yearly · 2025-12-31ProductRoyalty245,261,000USD0001193125-26-068925
    FY 2025Yearly · 2025-12-31ProductVivitrol467,912,000USD0001193125-26-068925
    Q3 2025Quarterly · 2025-09-30ProductAristada And Aristada Initio98,050,000USD0001193125-25-252524
    Q3 2025Quarterly · 2025-09-30ProductLYBALVI98,248,000USD0001193125-25-252524
    Q3 2025Quarterly · 2025-09-30ProductManufactured Product And Royalty — Manufacturing Revenue8,788,000USD0001193125-25-252524
    Q3 2025Quarterly · 2025-09-30ProductResearch And Development0USD0001193125-25-252524
    Q3 2025Quarterly · 2025-09-30ProductRoyalty67,974,000USD0001193125-25-252524
    Q3 2025Quarterly · 2025-09-30ProductVivitrol121,125,000USD0001193125-25-252524
    Q2 2025Quarterly · 2025-06-30ProductAristada And Aristada Initio101,295,000USD0000950170-25-099409
    Q2 2025Quarterly · 2025-06-30ProductLYBALVI84,280,000USD0000950170-25-099409
    Q2 2025Quarterly · 2025-06-30ProductManufactured Product And Royalty — Manufacturing Revenue16,567,000USD0000950170-25-099409
    Q2 2025Quarterly · 2025-06-30ProductResearch And Development0USD0000950170-25-099409
    Q2 2025Quarterly · 2025-06-30ProductRoyalty66,855,000USD0000950170-25-099409
    Q2 2025Quarterly · 2025-06-30ProductVivitrol121,660,000USD0000950170-25-099409
    Q1 2025Quarterly · 2025-03-31ProductAristada And Aristada Initio73,475,000USD0000950170-25-061817
    Q1 2025Quarterly · 2025-03-31ProductLYBALVI70,022,000USD0000950170-25-061817
    Q1 2025Quarterly · 2025-03-31ProductManufactured Product And Royalty — Manufacturing Revenue17,327,000USD0000950170-25-061817
    Q1 2025Quarterly · 2025-03-31ProductResearch And Development0USD0000950170-25-061817
    Q1 2025Quarterly · 2025-03-31ProductRoyalty44,690,000USD0000950170-25-061817
    Q1 2025Quarterly · 2025-03-31ProductVivitrol100,996,000USD0000950170-25-061817
    Q4 2024Quarterly · 2024-12-31ProductAristada And Aristada Initio96,616,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductLYBALVI76,977,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductManufactured Product And Royalty — Manufacturing Revenue53,169,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductResearch And Development0USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductRoyalty69,091,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductVivitrol134,133,000USDLegacy provider
    FY 2024Yearly · 2024-12-31GeographyForeign Country Excluding Specified Country146,179,000USD0001193125-26-068925
    FY 2024Yearly · 2024-12-31GeographyIE1,294,000USD0001193125-26-068925
    FY 2024Yearly · 2024-12-31GeographyUnited States1,410,159,000USD0001193125-26-068925
    FY 2024Yearly · 2024-12-31ProductAristada And Aristada Initio346,187,000USD0001193125-26-068925
    FY 2024Yearly · 2024-12-31ProductLYBALVI280,032,000USD0001193125-26-068925
    FY 2024Yearly · 2024-12-31ProductManufactured Product And Royalty — Manufacturing Revenue119,426,000USD0001193125-26-068925
    FY 2024Yearly · 2024-12-31ProductResearch And Development3,000USD0001193125-26-068925
    FY 2024Yearly · 2024-12-31ProductRoyalty354,669,000USD0001193125-26-068925
    FY 2024Yearly · 2024-12-31ProductVivitrol457,315,000USD0001193125-26-068925
    Q3 2024Quarterly · 2024-09-30ProductAristada And Aristada Initio84,652,000USD0001193125-25-252524
    Q3 2024Quarterly · 2024-09-30ProductLYBALVI74,697,000USD0001193125-25-252524
    Q3 2024Quarterly · 2024-09-30ProductManufactured Product And Royalty — Manufacturing Revenue15,947,000USD0001193125-25-252524
    Q3 2024Quarterly · 2024-09-30ProductResearch And Development0USD0001193125-25-252524
    Q3 2024Quarterly · 2024-09-30ProductRoyalty89,197,000USD0001193125-25-252524
    Q3 2024Quarterly · 2024-09-30ProductVivitrol113,650,000USD0001193125-25-252524
    Q2 2024Quarterly · 2024-06-30ProductAristada And Aristada Initio86,049,000USD0000950170-25-099409
    Q2 2024Quarterly · 2024-06-30ProductLYBALVI71,351,000USD0000950170-25-099409
    Q2 2024Quarterly · 2024-06-30ProductManufactured Product And Royalty — Manufacturing Revenue20,280,000USD0000950170-25-099409
    Q2 2024Quarterly · 2024-06-30ProductResearch And Development0USD0000950170-25-099409
    Q2 2024Quarterly · 2024-06-30ProductRoyalty109,578,000USD0000950170-25-099409
    Q2 2024Quarterly · 2024-06-30ProductVivitrol111,873,000USD0000950170-25-099409
    FY 2023Yearly · 2023-12-31GeographyForeign Country Excluding Specified Country170,287,000USD0001193125-26-068925
    FY 2023Yearly · 2023-12-31GeographyIE1,179,000USD0001193125-26-068925
    FY 2023Yearly · 2023-12-31GeographyUnited States1,491,939,000USD0001193125-26-068925
    FY 2023Yearly · 2023-12-31ProductAristada And Aristada Initio327,690,000USD0001193125-26-068925
    FY 2023Yearly · 2023-12-31ProductLYBALVI191,889,000USD0001193125-26-068925
    FY 2023Yearly · 2023-12-31ProductManufactured Product And Royalty — Manufacturing Revenue142,498,000USD0001193125-26-068925
    FY 2023Yearly · 2023-12-31ProductResearch And Development19,000USD0001193125-26-068925
    FY 2023Yearly · 2023-12-31ProductRoyalty600,890,000USD0001193125-26-068925
    FY 2023Yearly · 2023-12-31ProductVivitrol400,419,000USD0001193125-26-068925
    FY 2022Yearly · 2022-12-31GeographyForeign Country Excluding Specified Country177,975,000USD0000950170-25-019011
    FY 2022Yearly · 2022-12-31GeographyIE1,829,000USD0000950170-25-019011
    FY 2022Yearly · 2022-12-31GeographyUnited States931,991,000USD0000950170-25-019011
    FY 2022Yearly · 2022-12-31ProductAristada And Aristada Initio302,052,000USD0000950170-25-019011
    FY 2022Yearly · 2022-12-31ProductLicense2,000,000USD0000950170-25-019011
    FY 2022Yearly · 2022-12-31ProductLYBALVI96,022,000USD0000950170-25-019011
    FY 2022Yearly · 2022-12-31ProductManufactured Product And Royalty — Manufacturing Revenue112,374,000USD0000950170-25-019011
    FY 2022Yearly · 2022-12-31ProductResearch And Development260,000USD0000950170-25-019011
    FY 2022Yearly · 2022-12-31ProductRoyalty219,609,000USD0000950170-25-019011
    FY 2022Yearly · 2022-12-31ProductVivitrol379,478,000USD0000950170-25-019011
    FY 2021Yearly · 2021-12-31GeographyForeign Country Excluding Specified Country187,341,000USD0000950170-24-017883
    FY 2021Yearly · 2021-12-31GeographyIE2,175,000USD0000950170-24-017883
    FY 2021Yearly · 2021-12-31GeographyUnited States984,235,000USD0000950170-24-017883
    FY 2021Yearly · 2021-12-31ProductAristada And Aristada Initio275,356,000USD0000950170-24-017883
    FY 2021Yearly · 2021-12-31ProductLicense3,500,000USD0000950170-24-017883
    FY 2021Yearly · 2021-12-31ProductLYBALVI8,215,000USD0000950170-24-017883
    FY 2021Yearly · 2021-12-31ProductManufactured Product And Royalty — Manufacturing Revenue105,628,000USD0000950170-24-017883
    FY 2021Yearly · 2021-12-31ProductResearch And Development1,020,000USD0000950170-24-017883
    FY 2021Yearly · 2021-12-31ProductRoyalty436,179,000USD0000950170-24-017883
    FY 2021Yearly · 2021-12-31ProductVivitrol343,853,000USD0000950170-24-017883
    FY 2020Yearly · 2020-12-31GeographyForeign Country Excluding Specified Country196,528,000USD0001564590-23-002020
    FY 2020Yearly · 2020-12-31GeographyIE3,233,000USD0001564590-23-002020
    FY 2020Yearly · 2020-12-31GeographyUnited States838,995,000USD0001564590-23-002020
    FY 2020Yearly · 2020-12-31ProductAristada And Aristada Initio241,038,000USD0001564590-23-002020
    FY 2020Yearly · 2020-12-31ProductLicense1,050,000USD0001564590-23-002020
    FY 2020Yearly · 2020-12-31ProductManufactured Product And Royalty — Manufacturing Revenue119,034,000USD0001564590-23-002020

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.